André Nieoullon, Ph.D
Affiliations: | IBDML/Aix-Marseille University |
Google:
"André Nieoullon"Mean distance: 16.2 (cluster 6)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gouix E, Buisson A, Nieoullon A, et al. (2014) Oxygen glucose deprivation-induced astrocyte dysfunction provokes neuronal death through oxidative stress. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 87: 8-17 |
| Jean A, Laurent L, Bockaert J, et al. (2012) The nucleus accumbens 5-HTRâ‚„-CART pathway ties anorexia to hyperactivity. Translational Psychiatry. 2: e203 |
| Nieoullon A. (2010) [Acetylcholinesterase inhibitors in Alzheimer's disease: further comments on their mechanisms of action and therapeutic consequences]. Psychologie & Neuropsychiatrie Du Vieillissement. 8: 123-31 |
| Cornille E, Abou-Hamdan M, Khrestchatisky M, et al. (2010) Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury. Bmc Neuroscience. 11: 51 |
| Aliane V, Pérez S, Nieoullon A, et al. (2009) Cocaine-induced stereotypy is linked to an imbalance between the medial prefrontal and sensorimotor circuits of the basal ganglia. The European Journal of Neuroscience. 30: 1269-79 |
| Lortet S, Canolle B, Masmejean F, et al. (2008) Plasma membrane expression of the neuronal glutamate transporter EAAC1 is regulated by glial factors: evidence for different regulatory pathways associated with neuronal maturation. Neurochemistry International. 52: 1373-82 |
| Nafia I, Re DB, Masmejean F, et al. (2008) Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction. Journal of Neurochemistry. 105: 484-96 |
| Turle-Lorenzo N, Maurin B, Puma C, et al. (2006) The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. 319: 914-23 |
| Nieoullon A, Canolle B, Masmejean F, et al. (2006) The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse? Journal of Neurochemistry. 98: 1007-18 |
| Labrande C, Velly L, Canolle B, et al. (2006) Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa. Neuroscience. 137: 231-9 |